Developmental dysplasia of the hip (DDH) is a condition that affects 1-3% of newborns and is more common in females, firstborn children, and those with a positive family history or breech presentation. It used to be called congenital dislocation of the hip (CDH). DDH is more often found in the left hip and can be bilateral in 20% of cases. Screening for DDH is recommended for infants with certain risk factors, and all infants are screened using the Barlow and Ortolani tests at the newborn and six-week baby check. Clinical examination includes testing for leg length symmetry, restricted hip abduction, and knee level when hips and knees are flexed. Ultrasound is used to confirm the diagnosis if clinically suspected, but x-ray is the first line investigation for infants over 4.5 months. Management includes the use of a Pavlik harness for children under 4-5 months and surgery for older children with unstable hips.

In England and Wales, a child can provide consent for treatment, but cannot decline it. The demonstration of capacity, as per the Fraser guidelines, is not a significant factor.

Guidelines for Obtaining Consent in Children

The General Medical Council has provided guidelines for obtaining consent in children. According to these guidelines, young people who are 16 years or older can be treated as adults and are presumed to have the capacity to make decisions. However, for children under the age of 16, their ability to understand what is involved determines whether they have the capacity to decide. If a competent child refuses treatment, a person with parental responsibility or the court may authorize investigation or treatment that is in the child’s best interests.

When it comes to providing contraceptives to patients under 16 years of age, the Fraser Guidelines must be followed. These guidelines state that the young person must understand the professional’s advice, cannot be persuaded to inform their parents, is likely to begin or continue having sexual intercourse with or without contraceptive treatment, and will suffer physical or mental health consequences without contraceptive treatment. Additionally, the young person’s best interests require them to receive contraceptive advice or treatment with or without parental consent.

Some doctors use the term Fraser competency when referring to contraception and Gillick competency when referring to general issues of consent in children. However, rumors that Victoria Gillick removed her permission to use her name or applied copyright have been debunked. It is important to note that in Scotland, those with parental responsibility cannot authorize procedures that a competent child has refused.

Familial Short Stature in Children

Children who have short parents and are otherwise healthy may have familial short stature. This means that their height and weight fall within the expected range based on their parents’ heights, and growth charts can be used to predict their adult height. In the case of a girl with familial short stature, her predicted adult height would be 154 cm, which falls within the mid-parental range of heights. Delayed puberty would cause a failure to gain height at the beginning of puberty and crossing of height centiles, while inadequate nutrition would cause crossing of both height and weight centiles. Low birth weight can also cause short stature in children, but in the absence of any other history, familial short stature is the most likely explanation. Precocious puberty, on the other hand, causes children to be tall for their age at the onset of puberty, not short.

Neonatal jaundice is a common condition that affects many newborns, with up to 50% of term and 80% of preterm babies experiencing it in their first week of life. It is characterized by yellow discoloration of the skin and occurs when the serum bilirubin level exceeds 85 micromoles/l. Jaundice can be either physiological or pathological, with the former resulting from increased destruction of fetal erythrocytes and decreased liver function due to immaturity. Pathological jaundice, on the other hand, can be caused by haemolytic or non-haemolytic factors, impaired bilirubin conjugation or excretion, and post-hepatic anatomical malformations. Risk factors for neonatal jaundice include Asian origin, having a sibling with a history of the condition, metabolic disorders, prematurity, low birthweight, and being male. Prompt detection and treatment of jaundice is crucial to prevent kernicterus and severe brain damage. Other conditions that can cause neonatal jaundice include intravascular haemolysis, polycythaemia, biliary atresia, and congenital bile duct cysts.

Neonatal death is the term used to describe the death of a baby within the first 28 days of life. This classification is important for public health interventions and is a common topic in exams. Miscarriage, on the other hand, is defined as the death of a fetus before 24 weeks of gestation in the UK, or before 28 weeks globally. Puerperal death refers to the death of a mother within the first 6 weeks after giving birth. Perinatal death is a broader term that includes stillbirths and deaths within the first week of life, often resulting from obstetric events. Early neonatal death refers to death within the first week of life, while late neonatal death refers to death after 7 days but before 28 days of life.

Perinatal Death Rates and Related Metrics

Perinatal mortality rate is a measure of stillbirths and early neonatal deaths within seven days per 1,000 births after 24 weeks of gestation. In the UK, this rate is around 6 per 1,000 births. This figure is usually broken down into 4 per 1,000 stillbirths and 2 per 1,000 early neonatal deaths.

Maternal mortality rate, on the other hand, is calculated by dividing the number of deaths during pregnancy, labor, and six weeks after delivery by the total number of maternities and multiplying the result by 1000. Meanwhile, the stillbirth rate is determined by dividing the number of babies born dead after 24 weeks by the total number of births (live and stillborn) and multiplying the result by 1000. Lastly, the neonatal death rate is computed by dividing the number of babies who died between 0-28 days by the total number of live births and multiplying the result by 1000.

These metrics are important in assessing the quality of perinatal care and identifying areas for improvement. By monitoring these rates, healthcare providers can work towards reducing perinatal deaths and improving maternal and neonatal outcomes.

Forcible retraction should be avoided in younger children with phimosis, as it can lead to scar formation. It is important to note that phimosis is normal in children under the age of 2 and typically resolves on its own over time. Therefore, there is no urgent need for referral to paediatrics or paediatric surgeons. While lubricant is not helpful in managing phimosis, topical steroids have been found to be beneficial.

Phimosis in Children: When to Seek Treatment

Phimosis is a condition where the foreskin of the penis cannot be retracted. In children under two years old, this may be a normal physiological process that will resolve on its own. The British Association of Paediatric Urologists recommends an expectant approach in such cases, as forcible retraction can lead to scarring. However, personal hygiene is important to prevent infections. If the child is over two years old and experiences recurrent balanoposthitis or urinary tract infections, treatment can be considered.

It is important to note that parents should not attempt to forcibly retract the foreskin in young children. This can cause pain and scarring, and may not even be necessary. Instead, parents should focus on teaching their child good hygiene habits to prevent infections. If the child is experiencing recurrent infections or other symptoms, it may be time to seek medical treatment. By following these guidelines, parents can help their child manage phimosis and maintain good health.

Retinoblastoma: A Rare Eye Cancer with High Survival Rate but Risk of Secondary Malignancy

Retinoblastoma is a rare type of eye cancer that primarily affects children under the age of 5. It is characterized by an abnormal reflection in the pupil, appearing white instead of red, known as leucocoria. Most cases are caused by mutations in the retinoblastoma 1 (RB1) gene, located on chromosome 13, with one-third of cases being inherited in an autosomal dominant pattern. Surgical removal of the tumor, usually through enucleation, is the standard treatment, and the 5-year survival rate is almost 100% if diagnosed and treated promptly.

However, survivors of retinoblastoma are at risk of developing secondary non-ocular tumors, including malignant melanoma, sarcoma, brain tumors, leukemia, and osteosarcoma. Therefore, regular monitoring throughout life is necessary. Most cases are diagnosed before the age of 5, with 90% of cases being diagnosed before the child’s fifth birthday. It is important to note that retinoblastoma is not a recessive condition, and the RB1 gene is located on chromosome 13, not 16.

Tetralogy of Fallot is a congenital heart defect that typically presents at 1-2 months of age. It is characterized by four defects, including ventricular septal defect, right ventricular hypertrophy, overriding aorta, and right ventricular outflow tract obstruction (pulmonary stenosis). The severity of the pulmonary stenosis determines the degree of cyanosis and clinical severity, as more obstruction leads to more shunting and worse symptoms. Intermittent cyanotic episodes, tachypnea, and a harsh ejection-systolic murmur are common signs of TOF. Aortic stenosis, left ventricular hypertrophy, and right ventricular hypertrophy are not primary predictors of severity in TOF.

Understanding Tetralogy of Fallot

Tetralogy of Fallot (TOF) is a congenital heart disease that results from the anterior malalignment of the aorticopulmonary septum. It is the most common cause of cyanotic congenital heart disease, and it typically presents at around 1-2 months, although it may not be detected until the baby is 6 months old. The condition is characterized by four features, including ventricular septal defect (VSD), right ventricular hypertrophy, right ventricular outflow tract obstruction, and overriding aorta. The severity of the right ventricular outflow tract obstruction determines the degree of cyanosis and clinical severity.

Other features of TOF include cyanosis, which may cause episodic hypercyanotic ‘tet’ spells due to near occlusion of the right ventricular outflow tract. These spells are characterized by tachypnea and severe cyanosis that may occasionally result in loss of consciousness. They typically occur when an infant is upset, in pain, or has a fever, and they cause a right-to-left shunt. Additionally, TOF may cause an ejection systolic murmur due to pulmonary stenosis, and a right-sided aortic arch is seen in 25% of patients. Chest x-ray shows a ‘boot-shaped’ heart, while ECG shows right ventricular hypertrophy.

The management of TOF often involves surgical repair, which is usually undertaken in two parts. Cyanotic episodes may be helped by beta-blockers to reduce infundibular spasm. However, it is important to note that at birth, transposition of the great arteries is the more common lesion as patients with TOF generally present at around 1-2 months. Understanding the features and management of TOF is crucial for healthcare professionals to provide appropriate care and treatment for affected infants.

The primary reason for stridor in infants is laryngomalacia, which is characterized by a soft epiglottis that collapses into the airway during inhalation. Although it typically resolves on its own, if the stridor worsens and causes respiratory distress or hinders feeding, surgery may be necessary to enhance the airway.

Stridor in Children: Causes and Symptoms

Stridor is a high-pitched, wheezing sound that occurs during breathing and is commonly seen in children. There are several causes of stridor in children, including croup, acute epiglottitis, inhaled foreign body, and laryngomalacia. Croup is a viral infection that affects the upper respiratory tract and is characterized by stridor, barking cough, fever, and coryzal symptoms. Acute epiglottitis is a rare but serious infection caused by Haemophilus influenzae type B, which can lead to airway obstruction. Inhaled foreign body can cause sudden onset of coughing, choking, vomiting, and stridor, depending on the site of impaction. Laryngomalacia is a congenital abnormality of the larynx that typically presents at 4 weeks of age with stridor.

It is important to recognize the symptoms of stridor in children and seek prompt medical attention, especially if the child appears unwell or toxic. Treatment may include medications, such as corticosteroids or nebulized epinephrine, or in severe cases, intubation or tracheostomy. Prevention measures, such as vaccination against Haemophilus influenzae type B, can also help reduce the incidence of acute epiglottitis. Overall, early recognition and management of stridor in children can help prevent complications and improve outcomes.

If an infant under 6 months shows signs of an atypical UTI, it is important to schedule an ultrasound scan during their acute admission. Atypical UTI may be indicated by symptoms such as poor urine flow, an abdominal or bladder mass, raised creatinine, septicaemia, failure to respond to appropriate antibiotics within 48 hours, or infection with non-E. coli organisms. However, raised white blood cells alone do not necessarily indicate septicaemia, and abdominal pain is a common symptom of UTI but does not necessarily indicate an atypical UTI.

Urinary tract infections (UTI) are more common in boys until 3 months of age, after which the incidence is substantially higher in girls. Presentation in childhood depends on age, with infants showing poor feeding, vomiting, and irritability, younger children showing abdominal pain, fever, and dysuria, and older children showing dysuria, frequency, and haematuria. NICE guidelines recommend checking urine samples in children with symptoms or signs suggestive of a UTI, unexplained fever of 38°C or higher, or an alternative site of infection but who remain unwell. Urine collection should be done through clean catch or urine collection pads, and invasive methods should only be used if non-invasive methods are not possible. Management includes referral to a paediatrician for infants less than 3 months old, admission to hospital for children aged more than 3 months old with an upper UTI, and oral antibiotics for 3-10 days for children aged more than 3 months old with a lower UTI. Antibiotic prophylaxis is not given after the first UTI but should be considered with recurrent UTIs.

When answering questions about respiratory issues in newborns, it is important to consider the risk factors involved. Prematurity is the primary risk factor for neonatal respiratory distress syndrome (NRDS), while caesarean section increases the risk of tachypnea of the newborn (TTN). Meconium staining is a significant risk factor for aspiration pneumonia.

Symptoms of NRDS typically include respiratory distress that worsens over the first few days after birth. TTN, on the other hand, is characterized by rapid breathing shortly after birth, which often resolves within the first day of life. A chest X-ray can be helpful in diagnosing these conditions. NRDS is typically indicated by a diffuse ground glass appearance in the lungs, low lung volumes, and a bell-shaped thorax. TTN, on the other hand, may show a pattern similar to heart failure on the X-ray, with interstitial edema and pleural effusions, but with a normal heart size and rapid resolution of the pattern within a few days.

Surfactant Deficient Lung Disease in Premature Infants

Surfactant deficient lung disease (SDLD), previously known as hyaline membrane disease, is a condition that affects premature infants. It occurs due to the underproduction of surfactant and the immaturity of the lungs’ structure. The risk of SDLD decreases with gestation, with 50% of infants born at 26-28 weeks and 25% of infants born at 30-31 weeks being affected. Other risk factors include male sex, diabetic mothers, Caesarean section, and being the second born of premature twins.

The clinical features of SDLD are similar to those of respiratory distress in newborns, including tachypnea, intercostal recession, expiratory grunting, and cyanosis. Chest x-rays typically show a ground-glass appearance with an indistinct heart border.

Prevention during pregnancy involves administering maternal corticosteroids to induce fetal lung maturation. Management of SDLD includes oxygen therapy, assisted ventilation, and exogenous surfactant given via an endotracheal tube. With proper management, the prognosis for infants with SDLD is generally good.

When it comes to sexual issues involving young people, the topics of consent and confidentiality can be challenging. However, in this particular case, there is no ambiguity. Legally, individuals under the age of 13 are incapable of giving consent for sexual activity. Therefore, it is typically necessary to disclose this information. If there is a decision to withhold this information, it should be discussed with a designated doctor for child protection and documented appropriately. This is an uncommon occurrence. As the patient is under 13, she is unable to provide consent for sexual activity. While it may be necessary to discuss the situation with the patient’s mother, this is not the most urgent responsibility. The primary duty is to report the incident to the appropriate authority, and it cannot be left in the hands of the patient.

Guidelines for Obtaining Consent in Children

The General Medical Council has provided guidelines for obtaining consent in children. According to these guidelines, young people who are 16 years or older can be treated as adults and are presumed to have the capacity to make decisions. However, for children under the age of 16, their ability to understand what is involved determines whether they have the capacity to decide. If a competent child refuses treatment, a person with parental responsibility or the court may authorize investigation or treatment that is in the child’s best interests.

When it comes to providing contraceptives to patients under 16 years of age, the Fraser Guidelines must be followed. These guidelines state that the young person must understand the professional’s advice, cannot be persuaded to inform their parents, is likely to begin or continue having sexual intercourse with or without contraceptive treatment, and will suffer physical or mental health consequences without contraceptive treatment. Additionally, the young person’s best interests require them to receive contraceptive advice or treatment with or without parental consent.

Some doctors use the term Fraser competency when referring to contraception and Gillick competency when referring to general issues of consent in children. However, rumors that Victoria Gillick removed her permission to use her name or applied copyright have been debunked. It is important to note that in Scotland, those with parental responsibility cannot authorize procedures that a competent child has refused.

Measles: A Highly Infectious Viral Disease

Measles is a viral disease caused by an RNA paramyxovirus. It is one of the most infectious known viruses and is spread through aerosol transmission. The disease has an incubation period of 10-14 days and is infective from the prodromal phase until four days after the rash starts. Measles is now rare in developed countries due to immunization programs, but outbreaks can occur when vaccination rates drop, such as during the MMR controversy of the early 2000s.

The disease is characterized by a prodromal phase, which includes irritability, conjunctivitis, fever, and Koplik spots. The latter typically develop before the rash and are white spots on the buccal mucosa. The rash starts behind the ears and then spreads to the whole body, becoming a discrete maculopapular rash that may become blotchy and confluent. Desquamation may occur after a week, typically sparing the palms and soles. Diarrhea occurs in around 10% of patients.

Measles is mainly managed through supportive care, and admission may be considered in immunosuppressed or pregnant patients. The disease is notifiable, and public health should be informed. Complications of measles include otitis media, pneumonia (the most common cause of death), encephalitis (typically occurring 1-2 weeks following the onset of the illness), subacute sclerosing panencephalitis (very rare, may present 5-10 years following the illness), febrile convulsions, keratoconjunctivitis, corneal ulceration, diarrhea, increased incidence of appendicitis, and myocarditis.

If an unimmunized child comes into contact with measles, MMR should be offered within 72 hours. Vaccine-induced measles antibody develops more rapidly than that following natural infection.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at certain intervals. At 12-13 months, the Hib/Men C, MMR, and PCV vaccines are given, along with Men B. At 3-4 years, the ‘4-in-1 preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine will also be offered to new students (up to the age of 25 years) at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine. Students going to university or college for the first time as freshers, including overseas and mature students up to the age of 25, should contact their GP to have the Men ACWY vaccine, ideally before the start of the academic year.

It is worth noting that the Men C vaccine used to be given at 3 months but has now been discontinued. This is because the success of the Men C vaccination programme means there are almost no cases of Men C disease in babies or young children in the UK any longer. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

Managing Asthma in Children: NICE Guidelines

Asthma management in children has been updated by NICE in 2017, following the 2016 BTS guidelines. The new guidelines for children aged 5-16 are similar to those for adults, with a stepwise approach for treatment. For newly-diagnosed asthma, short-acting beta agonist (SABA) is recommended. If symptoms persist, a combination of SABA and paediatric low-dose inhaled corticosteroid (ICS) is used. Leukotriene receptor antagonist (LTRA) is added if symptoms still persist, followed by long-acting beta agonist (LABA) if necessary. Maintenance and reliever therapy (MART) is used as a combination of ICS and LABA for daily maintenance therapy and symptom relief. For children under 5 years old, clinical judgement plays a greater role in diagnosis. The stepwise approach is similar to that for older children, with an 8-week trial of paediatric moderate-dose ICS before adding LTRA. If symptoms persist, referral to a paediatric asthma specialist is recommended.

It should be noted that NICE does not recommend changing treatment for well-controlled asthma patients simply to adhere to the latest guidelines. The definitions of low, moderate, and high-dose ICS have also changed, with different definitions for adults and children. For children, <= 200 micrograms budesonide or equivalent is considered a paediatric low dose, 200-400 micrograms is a moderate dose, and > 400 micrograms is a high dose. Overall, the new NICE guidelines provide a clear and concise approach to managing asthma in children.

During the first 10 minutes after birth, it is normal for a healthy newborn to have SpO2 readings that are not optimal. It is also common for them to experience temporary cyanosis, which typically resolves on its own and does not require intervention. It is important to evaluate the baby’s appearance and color using the APGAR scoring system at 1 minute after birth, and then again at 5 and 10 minutes.

Cyanosis, a bluish discoloration of the skin, is a common occurrence in newborns. Peripheral cyanosis, which affects the hands and feet, is often seen in the first 24 hours of life and can be caused by crying or illness. Central cyanosis, on the other hand, is a more serious condition that occurs when the concentration of reduced hemoglobin in the blood exceeds 5g/dl. To differentiate between cardiac and non-cardiac causes of central cyanosis, doctors may use the nitrogen washout test, which involves giving the infant 100% oxygen for ten minutes and then measuring arterial blood gases. A pO2 of less than 15 kPa indicates cyanotic congenital heart disease, which can be caused by conditions such as tetralogy of Fallot, transposition of the great arteries, and tricuspid atresia.

If cyanotic congenital heart disease is suspected, initial management involves supportive care and the use of prostaglandin E1, such as alprostadil, to maintain a patent ductus arteriosus in ductal-dependent congenital heart defects. This can serve as a temporary measure until a definitive diagnosis is made and surgical correction is performed.

Acrocyanosis, a type of peripheral cyanosis, is a benign condition that is often seen in healthy newborns. It is characterized by bluish discoloration around the mouth and extremities, such as the hands and feet, and is caused by vasomotor changes that result in peripheral vasoconstriction and increased tissue oxygen extraction. Unlike other causes of peripheral cyanosis that may indicate significant pathology, such as septic shock, acrocyanosis occurs immediately after birth in healthy infants and typically resolves within 24 to 48 hours.

Pyloric stenosis is the probable diagnosis when a newborn experiences non-bilious vomiting during the first few weeks of life. This condition results in the loss of hydrochloric acid (HCl) from the stomach contents, leading to hypochloremia and potassium loss. The metabolic alkalosis is caused by the depletion of hydrogen ions due to the vomiting of stomach acid.

Understanding Pyloric Stenosis

Pyloric stenosis is a condition that usually occurs in infants between the second and fourth weeks of life. However, in rare cases, it may present later, up to four months. This condition is caused by the thickening of the circular muscles of the pylorus. Pyloric stenosis is more common in males, with an incidence of 4 per 1,000 live births. It is also more likely to affect first-borns and infants with a positive family history.

The most common symptom of pyloric stenosis is projectile vomiting, which usually occurs about 30 minutes after a feed. Other symptoms may include constipation, dehydration, and a palpable mass in the upper abdomen. Prolonged vomiting can lead to hypochloraemic, hypokalaemic alkalosis, which can be life-threatening.

Diagnosis of pyloric stenosis is typically made using ultrasound. Management of this condition involves a surgical procedure called Ramstedt pyloromyotomy. This procedure involves making a small incision in the pylorus to relieve the obstruction and allow for normal passage of food. With prompt diagnosis and treatment, infants with pyloric stenosis can make a full recovery.

Bronchiolitis is a condition where the bronchioles become inflamed, and it is most commonly caused by respiratory syncytial virus (RSV). This virus is responsible for 75-80% of cases, with other causes including mycoplasma and adenoviruses. Bronchiolitis is most prevalent in infants under one year old, with 90% of cases occurring in those aged 1-9 months. The condition is more serious in premature babies, those with congenital heart disease or cystic fibrosis. Symptoms include coryzal symptoms, dry cough, increasing breathlessness, and wheezing. Hospital admission is often necessary due to feeding difficulties associated with increasing dyspnoea.

Immediate referral is recommended if the child has apnoea, looks seriously unwell, has severe respiratory distress, central cyanosis, or persistent oxygen saturation of less than 92% when breathing air. Clinicians should consider referral if the child has a respiratory rate of over 60 breaths/minute, difficulty with breastfeeding or inadequate oral fluid intake, or clinical dehydration. Immunofluorescence of nasopharyngeal secretions may show RSV, and management is largely supportive. Humidified oxygen is given via a head box if oxygen saturations are persistently low, and nasogastric feeding may be necessary if children cannot take enough fluid/feed by mouth. Suction may also be used for excessive upper airway secretions. NICE released guidelines on bronchiolitis in 2015 for more information.

If you hear bowel sounds during a respiratory exam of a neonate experiencing respiratory distress, it may indicate the presence of a diaphragmatic hernia. This condition occurs when abdominal organs protrude through a hole in the diaphragm, typically on the left side, leading to underdeveloped lungs and breathing difficulties. The sound of bowel in the chest cavity causes the bowel sounds to be audible. The heart sounds may also be louder on the right side due to the displacement of the heart. The initial treatment involves inserting a nasogastric tube to prevent air from entering the gut, but for a cyanotic patient, intubation and ventilation are necessary. Surgical repair of the diaphragm is the definitive treatment. BIPAP and CPAP are not appropriate for this condition, as they are used to keep the airway open in conditions such as COPD or respiratory distress syndrome. Facemask ventilation and nasal cannulae should be avoided as they increase the risk of air entering the gut, and an artificial airway is necessary to ensure adequate oxygenation.

Understanding Congenital Diaphragmatic Hernia

Congenital diaphragmatic hernia (CDH) is a rare condition that affects approximately 1 in 2,000 newborns. It occurs when the diaphragm, a muscle that separates the chest and abdominal cavities, fails to form completely during fetal development. As a result, abdominal organs can move into the chest cavity, which can lead to underdeveloped lungs and high blood pressure in the lungs. This can cause respiratory distress shortly after birth.

The most common type of CDH is a left-sided posterolateral Bochdalek hernia, which accounts for about 85% of cases. This type of hernia occurs when the pleuroperitoneal canal, a structure that connects the chest and abdominal cavities during fetal development, fails to close properly.

Despite advances in medical treatment, only about 50% of newborns with CDH survive. Early diagnosis and prompt treatment are crucial for improving outcomes. Treatment may involve surgery to repair the diaphragm and move the abdominal organs back into their proper position. In some cases, a ventilator or extracorporeal membrane oxygenation (ECMO) may be necessary to support breathing until the lungs can function properly. Ongoing care and monitoring are also important to manage any long-term complications that may arise.

The automated otoacoustic emission test is the appropriate method for screening newborns for hearing problems. This test involves inserting a soft-tipped earpiece into the baby’s outer ear and emitting clicking sounds to detect a healthy cochlea. The auditory brainstem response test may be used if the baby does not pass the automated otoacoustic emission test. Play audiometry is only suitable for children between two and five years old, while pure tone audiometry is used for older children and adults and is not appropriate for newborns.

Hearing Tests for Children

Hearing tests are important for children to ensure that they are developing normally. There are several tests that may be performed on children of different ages. For newborns, an otoacoustic emission test is typically done as part of the Newborn Hearing Screening Programme. This test involves playing a computer-generated click through a small earpiece and checking for the presence of a soft echo, which indicates a healthy cochlea. If the results of this test are abnormal, an Auditory Brainstem Response test may be done.

For infants between 6-9 months, a Distraction test may be performed by a health visitor with the help of two trained staff members. For children between 18 months to 2.5 years, a Recognition of familiar objects test may be used, which involves using familiar objects like a teddy or cup and asking the child simple questions like where is the teddy? For children over 2.5 years, Performance testing and Speech discrimination tests may be used, such as the Kendall Toy test or McCormick Toy Test. Pure tone audiometry is typically done at school entry in most areas of the UK for children over 3 years old.

In addition to these tests, there is also a questionnaire for parents in the Personal Child Health Records called Can your baby hear you? It is important for parents to be aware of these tests and to have their child’s hearing checked regularly to ensure proper development.

When infants have whooping cough, they may not have the typical whoop sound due to their inability to take a deep breath after coughing. Instead, they may experience apnoeas and cyanosis. Based on the symptoms of coryza followed by severe coughing fits, it is likely that the cause of this child’s condition is Bordetella pertussis. Klebsiella pneumoniae is an unlikely cause as it typically affects patients in healthcare settings. Staphylococcus aureus commonly causes skin infections and pneumonia from this bacteria is more common after surgery. While Streptococcus pneumoniae can cause pneumococcal disease, which is a possibility in this case, it typically presents with sudden onset fever, malaise, and a cough with purulent or bloody sputum.

Whooping Cough: Causes, Symptoms, Diagnosis, and Management

Whooping cough, also known as pertussis, is a contagious disease caused by the bacterium Bordetella pertussis. It is commonly found in children, with around 1,000 cases reported annually in the UK. The disease is characterized by a persistent cough that can last up to 100 days, hence the name cough of 100 days.

Infants are particularly vulnerable to whooping cough, which is why routine immunization is recommended at 2, 3, 4 months, and 3-5 years. However, neither infection nor immunization provides lifelong protection, and adolescents and adults may still develop the disease.

Whooping cough has three phases: the catarrhal phase, the paroxysmal phase, and the convalescent phase. The catarrhal phase lasts around 1-2 weeks and presents symptoms similar to a viral upper respiratory tract infection. The paroxysmal phase is characterized by a severe cough that worsens at night and after feeding, and may be accompanied by vomiting and central cyanosis. The convalescent phase is when the cough subsides over weeks to months.

To diagnose whooping cough, a person must have an acute cough that has lasted for 14 days or more without another apparent cause, and have one or more of the following features: paroxysmal cough, inspiratory whoop, post-tussive vomiting, or undiagnosed apnoeic attacks in young infants. A nasal swab culture for Bordetella pertussis is used to confirm the diagnosis, although PCR and serology are increasingly used.

Infants under 6 months with suspected pertussis should be admitted, and in the UK, pertussis is a notifiable disease. An oral macrolide, such as clarithromycin, azithromycin, or erythromycin, is indicated if the onset of the cough is within the previous 21 days to eradicate the organism and reduce the spread. Household contacts should be offered antibiotic prophylaxis, although antibiotic therapy has not been shown to alter the course of the illness. School exclusion is recommended for 48 hours after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are given.

Complications of whooping cough include subconjunctival haemorrhage, pneumonia, bronchiectasis, and

Marfan syndrome is a connective tissue disease with cardiovascular complications such as aortic root dilation and aneurysm. Diagnosis is based on clinical features, family history, and genetic testing. The Ghent criteria are commonly used, with emphasis on cardiac manifestations. Echocardiographic surveillance is required, and prophylactic medications are used to reduce the chance of aortic root dilation. Aortic regurgitation may require surgery. Marfan syndrome is associated with non-cardiac features, and the clinical criteria can be found on the American National Marfan Foundation website.

If a patient presents with whooping cough within 21 days of the onset of cough, they should be prescribed either azithromycin or clarithromycin. In this case, the correct option is to prescribe oral clarithromycin. Hospital admission for IV antibiotics is not necessary as the patient is stable. If the patient had presented after three weeks, advice would be the appropriate course of action. Oral co-amoxiclav and oral doxycycline are not recommended treatments for whooping cough.

Whooping Cough: Causes, Symptoms, Diagnosis, and Management

Whooping cough, also known as pertussis, is a contagious disease caused by the bacterium Bordetella pertussis. It is commonly found in children, with around 1,000 cases reported annually in the UK. The disease is characterized by a persistent cough that can last up to 100 days, hence the name cough of 100 days.

Infants are particularly vulnerable to whooping cough, which is why routine immunization is recommended at 2, 3, 4 months, and 3-5 years. However, neither infection nor immunization provides lifelong protection, and adolescents and adults may still develop the disease.

Whooping cough has three phases: the catarrhal phase, the paroxysmal phase, and the convalescent phase. The catarrhal phase lasts around 1-2 weeks and presents symptoms similar to a viral upper respiratory tract infection. The paroxysmal phase is characterized by a severe cough that worsens at night and after feeding, and may be accompanied by vomiting and central cyanosis. The convalescent phase is when the cough subsides over weeks to months.

To diagnose whooping cough, a person must have an acute cough that has lasted for 14 days or more without another apparent cause, and have one or more of the following features: paroxysmal cough, inspiratory whoop, post-tussive vomiting, or undiagnosed apnoeic attacks in young infants. A nasal swab culture for Bordetella pertussis is used to confirm the diagnosis, although PCR and serology are increasingly used.

Infants under 6 months with suspected pertussis should be admitted, and in the UK, pertussis is a notifiable disease. An oral macrolide, such as clarithromycin, azithromycin, or erythromycin, is indicated if the onset of the cough is within the previous 21 days to eradicate the organism and reduce the spread. Household contacts should be offered antibiotic prophylaxis, although antibiotic therapy has not been shown to alter the course of the illness. School exclusion is recommended for 48 hours after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are given.

Complications of whooping cough include subconjunctival haemorrhage, pneumonia, bronchiectasis, and

DiGeorge Syndrome

DiGeorge syndrome is a genetic disorder caused by a deletion of chromosomal region 22q11.2. It affects around 1 in 3000 live births and is characterized by a spectrum of disorders. The poor migration of neural crest cells to the third and fourth pharyngeal pouches is thought to be the cause of the midline abnormalities found in DiGeorge syndrome. These abnormalities include cardiac defects, abnormal facies, thymic hypoplasia, and hypocalcemia.

Characteristic facies develop as the child grows and include high broad noses, low set ears, small teeth, and narrow eyes. Other systems may also be affected, and cognitive and psychiatric problems are common but variable. Around 80% of patients have an associated cardiac defect, often of a conotruncal variety. Tetralogy of Fallot is also found, as are other defects such as ventricular septal defects and atrial septal defects.

The diagnosis of DiGeorge syndrome can be difficult, but clinical features consistent with the diagnosis include abnormalities of heart sounds and features of cardiac failure or cyanosis. The chest x-ray helps with the diagnosis, and an echocardiogram and possibly high resolution contrast CT imaging would be helpful in these cases. The above example has a persistent truncus arteriosus, which is a failure to separate the aorta and the main pulmonary artery. This can lead to dyspnea, cyanosis, and cardiac failure.

In summary, DiGeorge syndrome is a complex disorder that affects multiple systems in the body. Early diagnosis and management are crucial to prevent complications and improve outcomes for affected individuals.

Understanding the Paediatric Glasgow Coma Scale (GCS)

The Paediatric Glasgow Coma Scale (GCS) is a tool used to assess the level of consciousness in children. It differentiates between children younger than 5 and those older than 5 years of age. The GCS measures three components: eye opening, verbal response, and motor activity. Each component is scored on a scale of 1 to 5 or 6, depending on the age of the child.

For example, a child who opens their eyes to pain (E2), flexes to pain (M3), and is moaning (V2) would score a total of 7 on the GCS. This child would be classified as having a GCS score of 7, not 5, 6, 8, or 9.

It is important to note that the British Paediatric Neurology Association has its own GCS scoring system for children, which may differ slightly from other versions. Understanding the GCS and its scoring system can help healthcare professionals accurately assess a child’s level of consciousness and determine appropriate treatment.

Kawasaki Disease: Diagnosis, Treatment, and Monitoring

Kawasaki disease is a febrile vasculitis affecting small to medium-sized arteries in children under the age of 5 years. Diagnosis is based on clinical presentation, including fever lasting for >5 days and at least four or five of the following: bilateral conjunctivitis, changes in the lips and oral mucosal cavities, lymphadenopathy, polymorphous rash, and changes in the extremities. Atypical cases may present with fewer symptoms. An echocardiogram is essential on admission to assess cardiac function and for the presence of aneurysms. Treatment involves inpatient care, intravenous immunoglobulins (IVIG), antipyretics, and monitoring of cardiovascular function. Corticosteroids may be used as an adjunct to IVIG. Aspirin is indicated for Kawasaki disease. Serial echocardiography is advised to monitor for any changes/worsening. If recognised early and treated appropriately, the prognosis is very good. If not, it carries a high morbidity as it is associated with the formation of arterial aneurysms and development of congestive heart disease. Other tests, such as ESR, throat swab, ASOT, and chest X-ray, may be performed but are not critical for the care and management of the patient.

Understanding Kawasaki Disease: Diagnosis, Treatment, and Monitoring

Pediatric Wheezing: Causes and Characteristics

Pediatric wheezing can be caused by various conditions, each with its own unique characteristics. Unilateral wheeze in a child under three years old is often associated with inhalation of a foreign body, which can partially or completely obstruct the airway. Bronchiolitis, typically caused by respiratory syncytial virus, initially presents as an upper respiratory tract infection and progresses to a lower respiratory tract infection with bilateral wheeze, cough, and difficulty breathing. Pneumonia may also cause wheezing, but is typically accompanied by systemic symptoms such as fever and crepitations on auscultation. Asthma, a common cause of pediatric wheezing, is characterized by bilateral expiratory wheezing due to premature bronchiole collapse. Croup, caused by a parainfluenza virus, presents with a barking cough, stridor, and respiratory distress, and is treated with dexamethasone.

Nocturnal enuresis, or bedwetting, is when a child involuntarily urinates during the night. Most children achieve continence by the age of 3 or 4, so enuresis is defined as the involuntary discharge of urine in a child aged 5 or older without any underlying medical conditions. Enuresis can be primary, meaning the child has never achieved continence, or secondary, meaning the child has been dry for at least 6 months before.

When managing bedwetting, it’s important to look for any underlying causes or triggers, such as constipation, diabetes mellitus, or recent onset UTIs. General advice includes monitoring fluid intake and encouraging regular toileting patterns, such as emptying the bladder before sleep. Reward systems, like star charts, can also be helpful, but should be given for agreed behavior rather than dry nights.

The first-line treatment for bedwetting is an enuresis alarm, which has a high success rate. These alarms have sensor pads that detect wetness and wake the child up to use the toilet. If short-term control is needed, such as for sleepovers, or if the alarm is ineffective or not acceptable to the family, desmopressin may be prescribed. Overall, managing bedwetting involves identifying any underlying causes and implementing strategies to promote continence.

The child in question has an asymptomatic murmur that is not an innocent murmur since it does not vary with position. The continuous machinery murmur heard at the upper left sternal edge is indicative of patent ductus arteriosus, a condition that is most common in premature babies like this one. In utero, the ductus arteriosus is a connection between the pulmonary artery and the aorta that allows blood to bypass the lungs. Normally, it closes within two days after birth.

It’s worth noting that other conditions present differently. For example, pulmonary stenosis is characterized by an ejection systolic murmur over the left upper sternal edge, while coarctation of the aorta presents with a systolic murmur under the left scapula and in the left infraclavicular area.

Patent ductus arteriosus is a type of congenital heart defect that is typically classified as ‘acyanotic’. However, if left untreated, it can eventually lead to late cyanosis in the lower extremities, which is known as differential cyanosis. This condition is caused by a connection between the pulmonary trunk and descending aorta that fails to close with the first breaths due to increased pulmonary flow that enhances prostaglandins clearance. Patent ductus arteriosus is more common in premature babies, those born at high altitude, or those whose mothers had rubella infection during the first trimester of pregnancy.

The features of patent ductus arteriosus include a left subclavicular thrill, a continuous ‘machinery’ murmur, a large volume, bounding, collapsing pulse, a wide pulse pressure, and a heaving apex beat. To manage this condition, indomethacin or ibuprofen is given to the neonate, which inhibits prostaglandin synthesis and closes the connection in the majority of cases. If patent ductus arteriosus is associated with another congenital heart defect that is amenable to surgery, then prostaglandin E1 is useful to keep the duct open until after surgical repair.

Understanding Obesity in Children

Childhood obesity is a complex issue that requires careful assessment and management. Unlike adults, defining obesity in children is more challenging as body mass index (BMI) varies with age. To accurately assess BMI, percentile charts are needed. According to recent guidelines by the National Institute for Health and Care Excellence (NICE), the UK 1990 BMI charts should be used to provide age- and gender-specific information.

NICE recommends tailored clinical intervention if BMI is at the 91st centile or above. If BMI is at the 98th centile or above, assessing for comorbidities is necessary. Lifestyle factors are the most common cause of obesity in childhood. However, other factors such as growth hormone deficiency, hypothyroidism, Down’s syndrome, Cushing’s syndrome, and Prader-Willi syndrome can also contribute to obesity in children.

Obesity in children can lead to various consequences, including orthopaedic problems such as slipped upper femoral epiphysis and Blount’s disease, musculoskeletal pains, psychological consequences like poor self-esteem and bullying, sleep apnoea, and benign intracranial hypertension. Moreover, obesity in childhood can increase the risk of developing type 2 diabetes mellitus, hypertension, and ischaemic heart disease in the long run. Therefore, it is crucial to identify and manage obesity in children to prevent these adverse outcomes.